Showing results (201-210 of 289) with videos related to
Sort By:
Pageof 29
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 29, 2000
Increased targeting of adenine-rich sequences by (2-amino-2-methyl-3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicityT W Hambley, E C Ling, S O'Mara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Multiple atypical nevi: a cutaneous marker of germ cell tumorsD Raghavan, J R Zalcberg, J J Grygiel, et al.British Journal of Urology|April 1, 1987
Aminoglutethimide in advanced prostatic carcinomaP R Harnett, D Raghavan, I Caterson, et al.British Journal of Urology|May 1, 1992
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinomaM A Rosenthal, K Cox, D Raghavan, et al.Cancer Letters|August 11, 2000
Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell linesP Jackson, D Millar, E Kingsley, et al.Annals of Surgical Oncology|November 1, 1996
Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumorsJ L Yang, K T Ow, P J Russell, et al.The Journal of Pathology|April 18, 2000
Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancerK Ow, W Delprado, R Fisher, et al.Analytical Biochemistry|July 1, 1987
Methods for DNA extraction from Candida albicansP M Glee, P J Russell, J A Welsch, et al.Cell Biophysics|January 1, 1994
Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancerP J Russell, K Davis, E Kingsley, et al.Anticancer Research|June 6, 1998
Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activatorC R Berney, J L Yang, R J Fisher, et al.Pageof 29